1 document found, page 1 of 1

Sort by Issue Date

Polythylene glycol severe allergy and SARS-CoV-2 vaccines

Gaspar, A; Moura, A L; Cruz, C; BORREGO, LUIS MIGUEL

Background. Polyethylene glycol (PEG) is being used for first time as an excipient for mRNA anti-SARS-CoV-2 vaccines containing-PEG2000, highlighting it as a potential cause of anaphylaxis. Objective. To assess the usefulness of skin tests using PEG1500 extract in patients with suspected allergy to SARS-CoV-2 vaccines. Methods. We evaluated 126 patients with moderate-high risk of allergy to SARS-CoV-2 vaccines ...


1 Results

Queried text

Refine Results

Author





Date


Document Type


Access rights


Resource


Subject